Skip to content

Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people

Juan Macías of Hospital Universitario de Valme in Seville, Spain. © Liz Highleyman / hivandhepatitis.com

First-line antiretroviral therapy has improved over time, meta-analysis shows

Frederick Lee of St. Vincent's Centre for Applied Medical Research in Sydney. Photo by Liz Highleyman, hivandhepatitis.com.

Ambitious plans for treatment as prevention in Asia, but challenges remain

Dr Fujie Zhang of the National Center for AIDS/STD Prevention and Control (NCAIDS) presenting at IAS 2013. Photo ©International AIDS Society/Marcus Rose/Workers' Photos.

Reduced efavirenz dose suppresses HIV as well as standard dose

Rebekah Puls of the Kirby Institute in Sydney presenting at IAS 2013. Photo©International AIDS Society/Steve Forrest/Workers' Photos.

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

Nicholas Paton of the Europe-Africa Research Network for Evaluation of Second-line Therapy (EARNEST). Photo by Jan Brittenson, hivandhepatitis.com.

First-ever community-randomised combination prevention trial produces modest drop in HIV incidence, big increase in testing in men

Project ACCEPT mobile testing unit.

High linkage to care after community-based HIV counselling and testing in South Africa associated with confidence in drug supplies, depression

Images from the presentation of Reshma Naik.

New recommendations on HIV treatment for children require earlier diagnosis, new drug combinations for maximum impact

Chewe Luo from UNICEF, at IAS 2013. Photo ©International AIDS Society/Steve Forrest/Workers' Photos

High positivity rate and good linkage to care at Barcelona community testing project

BCN Checkpoint in Barcelona, Spain.